Literature DB >> 655107

Arterial thrombosis in essential thrombocythemia.

S Hussain, J M Schwartz, S A Friedman, S N Chua.   

Abstract

The course of essential thrombocythemia has been observed in ten patients, ages 46 to 83, of whom nine were followed for a period of 4 months to 9 years. In contrast to the experience with essential thrombocythemia recorded in the literature, manifestations of arterial thrombosis were far more common than hemorrhage. In six of the ten patients, the presenting complaints were ascribable to incipient gangrene of the toes and several of these patients additionally developed occlusion of tibial and larger arteries while under our observation. All patients with incipient gangrene showed marked clinical improvement accompanying busulfan-induced reduction and normalization of the platelet count. Relapses in five patients after 2 to 87 months responded well to retreatment with busulfan. No patient has shown evolution to another myeloproliferative disorder. Essential thrombocythemia should be considered in the differential diagnosis of occlusive arterial disease.

Entities:  

Mesh:

Year:  1978        PMID: 655107     DOI: 10.1016/0002-8703(78)90123-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  [Acute myocardial infarct caused by nicotine-induced erythrocytosis].

Authors:  S Andreas; K S Herrmann; H Kreuzer; V Wiegand
Journal:  Klin Wochenschr       Date:  1989-10-02

2.  Thrombocytosis in young people: evaluation of 57 cases diagnosed before the age of 40.

Authors:  M L Randi; F Fabris; A Girolami
Journal:  Blut       Date:  1990-04

3.  [Clinical characterization of essential thrombocythemia in comparison with other myeloproliferative diseases and reactive thrombocytoses].

Authors:  M Jahn; B Zönnchen; W Köpcke; R Hehlmann
Journal:  Klin Wochenschr       Date:  1988-03-01

4.  [Thrombocyte function in essential thrombocythemia and reactive thrombocytosis].

Authors:  B Baumann; I Hillmar; R Hehlmann
Journal:  Klin Wochenschr       Date:  1988-03-01

5.  Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a.

Authors:  A Tichelli; A Gratwohl; C Berger; A Lori; A Würsch; A Dieterle; C Thomssen; C Nissen; E Holdener; B Speck
Journal:  Blut       Date:  1989-01

6.  Recurrent transient ischemic attacks associated with thrombocytosis in rheumatoid arthritis.

Authors:  A Pines; N Kaplinsky; D Olchovsky; J Bregman; O Frankl
Journal:  Clin Rheumatol       Date:  1982-12       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.